Tyrosine Hydroxylase- and Dopamine Transporter-Immunoreactive Axons in the Primate Cerebellum

[1]  S. Haber,et al.  Immunocytochemical localization of the dopamine transporter in human brain , 1999, The Journal of comparative neurology.

[2]  A. Rivera,et al.  Differential regional and cellular distribution of dopamine D2‐like receptors: An immunocytochemical study of subtype‐specific antibodies in rat and human brain , 1998, The Journal of comparative neurology.

[3]  K. D. Tran,et al.  Reduced Purkinje cell size in the cerebellar vermis of elderly patients with schizophrenia. , 1998, The American journal of psychiatry.

[4]  Allan I. Levey,et al.  Dopamine Axon Varicosities in the Prelimbic Division of the Rat Prefrontal Cortex Exhibit Sparse Immunoreactivity for the Dopamine Transporter , 1998, The Journal of Neuroscience.

[5]  J. Schmahmann,et al.  The cerebellar cognitive affective syndrome. , 1998, Brain : a journal of neurology.

[6]  M. Kuhar.  Recent biochemical studies of the dopamine transporter--a CNS drug target. , 1998, Life sciences.

[7]  C Kennard,et al.  Oculomotor abnormalities in schizophrenia , 1998, Neurology.

[8]  S. Sesack,et al.  Dopamine axons in primate prefrontal cortex: specificity of distribution, synaptic targets, and development. , 1998, Advances in pharmacology.

[9]  P. Goldman-Rakic.  The cortical dopamine system: role in memory and cognition. , 1998, Advances in pharmacology.

[10]  J N Giedd,et al.  Quantitative morphology of the cerebellum and fourth ventricle in childhood-onset schizophrenia. , 1997, The American journal of psychiatry.

[11]  G McKay,et al.  PET evidence that loxapine is an equipotent blocker of 5-HT2 and D2 receptors: implications for the therapeutics of schizophrenia. , 1997, The American journal of psychiatry.

[12]  M. Caron,et al.  The dopamine transporter: A crucial component regulating dopamine transmission , 1997, Movement disorders : official journal of the Movement Disorder Society.

[13]  A Carlsson,et al.  Neurotransmitter aberrations in schizophrenia: new perspectives and therapeutic implications. , 1997, Life sciences.

[14]  D. Mash,et al.  Immunochemical analysis of dopamine transporter protein in Parkinson's disease , 1997, Annals of neurology.

[15]  Effect of haloperidol dose on iodine-123-IBZM brain SPECT imaging in schizophrenic patients. , 1997, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[16]  S. Sesack,et al.  Chapter VI Dopamine systems in the primate brain , 1997 .

[17]  J. B. Levitt,et al.  Patterns of intrinsic and associational circuitry in monkey prefrontal cortex , 1996, The Journal of comparative neurology.

[18]  Christer Halldin,et al.  Test-retest reliability of central [11C]raclopride binding at high D2 receptor occupancy. A PET study in haloperidol-treated patients , 1996, Psychiatry Research: Neuroimaging.

[19]  N C Andreasen,et al.  Schizophrenia and cognitive dysmetria: a positron-emission tomography study of dysfunctional prefrontal-thalamic-cerebellar circuitry. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[20]  Adriaan A. Lammertsma,et al.  The potential of high-resolution positron emission tomography to monitor striatal dopaminergic function in rat models of disease , 1996, Journal of Neuroscience Methods.

[21]  N. Volkow,et al.  MR-PET image coregistration for quantitation of striatal dopamine D2 receptors. , 1996, Journal of computer assisted tomography.

[22]  G. Uhl,et al.  Dopamine transporter immunoreactivity in rat brain , 1995, The Journal of comparative neurology.

[23]  F. Moeller,et al.  Cerebellar blood flow in schizophrenic patients and normal control subjects , 1995, Psychiatry Research: Neuroimaging.

[24]  M. Martres,et al.  Phenotypical characterization of neurons expressing the dopamine D3 receptor in the rat brain , 1995, Neuroscience.

[25]  S. Hersch,et al.  The dopamine transporter: immunochemical characterization and localization in brain , 1995, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[26]  P. Strick,et al.  Anatomical evidence for cerebellar and basal ganglia involvement in higher cognitive function. , 1994, Science.

[27]  J. Haycock,et al.  Expression and distribution of two isoforms of tyrosine hydroxylase in macaque monkey brain , 1994, Brain Research.

[28]  M. Egan,et al.  Dopamine release in the rat cerebellum and hippocampus: a tissue 3-methoxytyramine study , 1994, Brain Research.

[29]  P. Strick,et al.  Activation of a cerebellar output nucleus during cognitive processing. , 1994, Science.

[30]  N. Mendell,et al.  Eye tracking and schizophrenia: a selective review. , 1994, Schizophrenia bulletin.

[31]  M. Akil,et al.  The dopaminergic innervation of monkey entorhinal cortex. , 1993, Cerebral cortex.

[32]  A. Fuchs,et al.  Role of the caudal fastigial nucleus in saccade generation. I. Neuronal discharge pattern. , 1993, Journal of neurophysiology.

[33]  J. Haycock,et al.  Four isoforms of tyrosine hydroxylase are expressed in human brain , 1993, Neuroscience.

[34]  E Ryding,et al.  Motor imagery activates the cerebellum regionally. A SPECT rCBF study with 99mTc-HMPAO. , 1993, Brain research. Cognitive brain research.

[35]  S E Petersen,et al.  The processing of single words studied with positron emission tomography. , 1993, Annual review of neuroscience.

[36]  N. Mizuno,et al.  Dopaminergic and non-dopaminergic neurons in the ventral tegmental area of the rat project, respectively, to the cerebellar cortex and deep cerebellar nuclei , 1992, Neuroscience.

[37]  N. Volkow,et al.  Low cerebellar metabolism in medicated patients with chronic schizophrenia. , 1992, The American journal of psychiatry.

[38]  A. Grace.  Phasic versus tonic dopamine release and the modulation of dopamine system responsivity: A hypothesis for the etiology of schizophrenia , 1991, Neuroscience.

[39]  K. Davis,et al.  Dopamine in schizophrenia: a review and reconceptualization. , 1991, The American journal of psychiatry.

[40]  J. Schmahmann.  An emerging concept. The cerebellar contribution to higher function. , 1991, Archives of neurology.

[41]  N. Panagopoulos,et al.  Dopaminergic innervation and binding in the rat cerebellum , 1991, Neuroscience Letters.

[42]  M. Wolf,et al.  Effect of Aging on Tyrosine Hydroxylase Protein Content and the Relative Number of Dopamine Nerve Terminals in Human Caudate , 1991, Journal of neurochemistry.

[43]  P. Goldman-Rakic,et al.  D1 dopamine receptors in prefrontal cortex: involvement in working memory , 1991, Science.

[44]  B. Berger,et al.  Dopaminergic innervation of the cerebral cortex: unexpected differences between rodents and primates , 1991, Trends in Neurosciences.

[45]  Kisou Kubota,et al.  Dopamine enhances the neuronal activity of spatial short-term memory task in the primate prefrontal cortex , 1988, Neuroscience Research.

[46]  Masao Ito.  The Cerebellum And Neural Control , 1984 .

[47]  T. Vilis,et al.  Characteristics of saccadic dysmetria in monkeys during reversible lesions of medial cerebellar nuclei. , 1981, Journal of neurophysiology.

[48]  S. Hsu,et al.  Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures. , 1981, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[49]  J. Kleinman,et al.  Cerebellar pathology in schizophrenia: a controlled postmortem study. , 1980, The American journal of psychiatry.

[50]  H. E. Rosvold,et al.  Cognitive deficit caused by regional depletion of dopamine in prefrontal cortex of rhesus monkey. , 1979, Science.

[51]  A. Björklund,et al.  Organization of Catecholamine Neurons in the Rat Central Nervous System , 1978 .

[52]  Dominic W. Hughes,et al.  Eye-Tracking Patterns in Schizophrenia , 1973, Science.

[53]  S. Snyder,et al.  Catecholamines in the brain as mediators of amphetamine psychosis. , 1972, Archives of general psychiatry.

[54]  M. Carpenter,et al.  Cerebellum of the rhesus monkey : atlas of lobules, laminae, and folia, in sections , 1971 .

[55]  Á.,et al.  Antibodies directed against tyrosine hydroxylase differentially recognize noradrenergic axons in monkey neocortex , 2022 .